NCCN Guidelines Insights: Antiemesis, Version 2.2017.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2017.0117
Abstract: The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Antiemesis address all aspects of management for chemotherapy-induced nausea and vomiting. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Antiemesis,… read more here.
Keywords: nccn guidelines; insights antiemesis; version 2017; antiemesis version ... See more keywords
Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2017.0131
Abstract: Ductal adenocarcinoma and its variants account for most pancreatic malignancies. High-quality multiphase imaging can help to preoperatively distinguish between patients eligible for resection with curative intent and those with unresectable disease. Systemic therapy is used… read more here.
Keywords: 2017 nccn; pancreatic adenocarcinoma; version 2017; oncology ... See more keywords
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2018.0012
Abstract: Ductal carcinoma in situ (DCIS) of the breast represents a heterogeneous group of neoplastic lesions in the breast ducts. The goal for management of DCIS is to prevent the development of invasive breast cancer. This… read more here.
Keywords: breast; cancer version; breast cancer; version 2017 ... See more keywords